Out-licencing and Partnerships
Product or program
Indication
Tesofensine
Obesity
NS2359
Cocaine addiction
CAD-1883
Essential tremor
Spinocerebellar ataxia
GABA a5
Schizophrenia
Undisclosed
Schizophrenia